EFDID: 509410EFD: View Filing

Issuer: Aspira Women's Health Inc. (0000926617) - D

Accession: 0002010585-24-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0000926617
  • Entity Name:
    Aspira Women's Health Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    12117 BEE CAVES ROAD BUILDING THREE
    SUITE 100
    AUSTIN, TX 78738
  • Persons:
    Related Persons 9
    Nicole Sandford
    Executive Officer, Director
    Minh Merchant
    Executive Officer
    Celeste Fralick
    Director
    Torsten Hombeck
    Executive Officer
    Jody Berry
    Executive Officer
    Jannie Herchuk
    Director
    Stefanie Cavanaugh
    Director
    Lynn O'Connor Vos
    Director
    Winfred Parnell
    Director
EDGAR: Offering Information
  • Accession Date:
    02/07/2024
  • First Sale Date:
    01/26/2024
  • Offering Amount:
    $6,488,230
  • Amount Sold:
    $6,488,230
  • Exemptions:
    Rule 506
  • Security Type(s):
  • Sales Clarification:
    The total offering amount and total amount sold represent the aggregate exercise price of certain warrants to purchase shares of capital stock of the Issuer.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Aspira Women's Health Inc./s/ Nicole SandfordNicole SandfordPresident and CEO2024-02-07